Baltimore, MD, United States of America

Simeon Springer

USPTO Granted Patents = 3 

Average Co-Inventor Count = 8.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Simeon Springer: Pioneering Cancer Detection Methods

Introduction

Simeon Springer is a prominent inventor based in Baltimore, MD, who has significantly contributed to the field of cancer research through his innovative patents. With a total of three patents to his name, he has focused on developing advanced methods for detecting and treating head and neck squamous cell carcinoma (HNSCC).

Latest Patents

One of Springer's latest patents involves groundbreaking assays for detecting head and neck squamous cell carcinoma. In this research, DNA was extracted from the saliva and plasma of 93 HNSCC patients, where tumor DNA was identified in 96% of those tested. This study indicated that saliva tends to be enriched with tumor DNA from the oral cavity, while plasma is more indicative of tumor DNA from other sites. The findings suggest that these tumor DNA markers are invaluable for HNSCC detection.

Additionally, Springer has patent protections for methods and materials aimed at assessing and treating cancer. His innovative approaches include identifying localized cancers through the detection of various classes of biomarkers and evaluating aneuploidy for improved sensitivity and specificity in cancer detection. These contributions hold great promise for transformative advances in cancer diagnostics.

Career Highlights

Simeon Springer has had an illustrious career within esteemed research institutions. He has worked at The Johns Hopkins University and the University of Texas System, both of which are renowned for their contributions to medical sciences and research. His work has not only advanced scientific understanding but also paved the way for practical applications in clinical settings.

Collaborations

Springer has collaborated with notable figures in the field, such as Bert Vogelstein and Kenneth W. Kinzler. These partnerships have fostered innovation and have been instrumental in advancing the methodologies used to detect and treat cancer. The synergy between these accomplished researchers has yielded significant advancements in cancer diagnostics.

Conclusion

Simeon Springer’s contributions as an inventor have marked a significant impact in the realm of cancer detection and treatment. His research and patented methods have the potential to revolutionize how cancers, particularly head and neck squamous cell carcinoma, are diagnosed and tackled. With his innovative spirit and collaborative efforts, Springer continues to lead the charge in the fight against cancer, inspiring future advancements in this critical area of health care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…